Stoke Therapeutics, Inc. STOK Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s quick ratio?
- Stoke Therapeutics, Inc. (STOK) reported quick ratio of 9× in Q1 2026.
- How has Stoke Therapeutics, Inc.'s quick ratio changed year-over-year?
- Stoke Therapeutics, Inc.'s quick ratio increased by 6.9% year-over-year, from 8.4× to 9×.
- What is the long-term trend for Stoke Therapeutics, Inc.'s quick ratio?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s quick ratio has grown at a -27.1% compound annual growth rate (CAGR), from 25.7× to 5.3×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.